• Forum
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Get in touch
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

Wirtek

4.34 DKK

+0.93 %

Less than 1K followers

WIRTEK

First North Denmark

Telecommunications

Technology

Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Compare
+0.93 %
-2.25 %
-15.73 %
-9.96 %
-12.15 %
-28.85 %
-64.43 %
-79.43 %
-90.96 %

WirTek is an IT company. The company is focused on developing software and hardware solutions that affect web, mobile and integrated complete systems. Operations are held on a global level, with the largest presence in the Nordic region and Europe, where customers mainly consist of small and medium-sized business customers. WirTek was founded in 2001 and is headquartered in Aalborg.

Read more
Market cap
34.38M DKK
Turnover
21.69K DKK
Revenue
64.35M
EBIT %
-1.65 %
P/E
-
Dividend yield-%
-
Coverage
Disclaimer
Latest research

Latest analysis report

Released: 18.05.2026

Revenue and EBIT-%
EPS and dividend
Financial calendar
All
Research
Webcasts
Press releases
ShowingAll content types

Revenue and EBIT-%

Revenue M

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Financial calendar
12.8
2026

Interim report Q2'26

11.11
2026

Interim report Q3'26

Press release6/11/2026, 9:50 AM

Vækstaktier.dk: Wirtek gør klar til nyt opkøb og underskriver Letter of Intent

Wirtek
Press release6/11/2026, 9:50 AM

Vækstaktier.dk: Wirtek Prepares for New Acquisition and Signs Letter of Intent

Wirtek
Wirtek: Indgår ikke-bindende aftale om opkøb af dansk SaaS-selskab
Analyst Comment6/11/2026, 8:26 AM by
Michael Friis

Wirtek: Indgår ikke-bindende aftale om opkøb af dansk SaaS-selskab

Wirtek eksekverer på strategien med ikke-bindende opkøbsaftale om profitabelt dansk SaaS-selskab. Et opkøb, der kan understøtte skiftet fra timebaserede services mod løsninger med tilbagevendende omsætning og blue-chip kunder i life sciences, forsvar og energi

Wirtek

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account
Regulatory press release6/11/2026, 7:03 AM

Wirtek A/S: Wirtek signs non-binding acquisition agreement

Wirtek
Dagens aktienyheder 18/05-2026: WindowMaster, RTX, Wirtek og Ascelia Pharma
Analyst Comment5/18/2026, 6:59 AM by
Michael Friis, Rasmus Køjborg

Dagens aktienyheder 18/05-2026: WindowMaster, RTX, Wirtek og Ascelia Pharma

Dagens aktienyheder 18/05-2026: WindowMaster, RTX, Wirtek og Ascelia Pharma

WindowMaster InternationalRTXWirtekAscelia Pharma
Wirtek (Investment case): Strategy execution shows first proof points
Research5/18/2026, 5:00 AM by
Michael Friis, Victor Skriver

Wirtek (Investment case): Strategy execution shows first proof points

Following Wirtek's Q1 2026 interim report, we have updated our investment case to reflect the first full quarter of impact from the new strategy launched last year. Our investment case covers the key investment reasons and risks and valuation perspectives.

Wirtek
Press release5/13/2026, 1:15 PM

Vækstaktier.dk: Wirtek leverer stabil omsætning og positivt EBITDA i første kvartal 2026

Wirtek
Press release5/13/2026, 1:15 PM

Vækstaktier.dk: Wirtek delivers stable revenue and positive EBITDA in the first quarter of 2026

Wirtek
Wirtek: Recording of Q1 2026 results presentation
Analyst Comment5/13/2026, 12:02 PM by
Michael Friis

Wirtek: Recording of Q1 2026 results presentation

Today, Wirtek’s CEO Michael Aaen and CFO Mads Greiffenberg presented the company’s Q1 2026 results , and what is driving the increased profitability despite muted topline growth The presentation was followed by a Q&A session.

Wirtek
Wirtek – Presentation of Q1 2026 Interim Report
Webcast5/13/2026, 10:30 AM

Wirtek – Presentation of Q1 2026 Interim Report

Wirtek is expected to release its Q1 2026 interim report on May 13, 2026. On the same day at 12:30 CEST, CEO Michael Aaen and CFO Mads Greiffenberg will present the results in a virtual live event with a Q&A session. In connection with the 2025 annual report, Wirtek launched guidance for 2026 with revenue in the range of DKK 65-70m (growth of 1-9% compared to 2025) and EBITDA of DKK 3-6m (compared to DKK 1.7m in 2025). The guidance signals a return to growth and significantly improved profitability following a transitional year in 2025.

Wirtek
Regulatory press release5/13/2026, 8:33 AM

Interim Report Q1 2026: Strategy execution delivers margin recovery on stable revenue

Wirtek
Mød ledelsen i H. Lundbeck, Wirtek, Ascelia Pharma og GrønlandsBANKEN, og stil spørgsmål til dagens investorpræsentationer
Analyst Comment5/13/2026, 6:30 AM by
Victor Skriver

Mød ledelsen i H. Lundbeck, Wirtek, Ascelia Pharma og GrønlandsBANKEN, og stil spørgsmål til dagens investorpræsentationer

Mød ledelsen i H. Lundbeck, Wirtek, Ascelia Pharma og GrønlandsBANKEN, og stil spørgsmål til dagens investorpræsentationer

LundbeckWirtekAscelia PharmaGrønlandsbanken
Press release4/22/2026, 7:45 AM

Vækstaktier.dk: Wirtek fastholder udlodningspolitikken trods droppet udbytte i 2026

Wirtek
Press release4/22/2026, 7:45 AM

Vækstaktier.dk: Wirtek maintains its distribution policy despite suspended dividend in 2026

Wirtek
Regulatory press release4/15/2026, 2:30 PM

Referat af ordinær generalforsamling i Wirtek A/S

Wirtek
Regulatory press release4/15/2026, 2:30 PM

Minutes from Annual General Meeting in Wirtek A/S

Wirtek
Regulatory press release3/24/2026, 9:01 AM

Notice to convene Annual General Meeting in Wirtek A/S

Wirtek
Regulatory press release3/24/2026, 9:01 AM

Indkaldelse til ordinær generalforsamling i Wirtek A/S

Wirtek
Dagens aktienyheder 23/03-2026: Flügger, Danish Aerospace Company, Roblon og Wirtek
Analyst Comment3/23/2026, 8:04 AM by
Michael Friis, Rasmus Køjborg

Dagens aktienyheder 23/03-2026: Flügger, Danish Aerospace Company, Roblon og Wirtek

Dagens aktienyheder 23/03-2026: Flügger, Danish Aerospace Company, Roblon og Wirtek

Flügger GroupDanish Aerospace and Defence CompanyWirtekRoblon
Wirtek (Investment case): Well-positioned to increase profitability
Research3/20/2026, 1:30 PM by
Michael Friis, Victor Skriver

Wirtek (Investment case): Well-positioned to increase profitability

In connection with the publication of Wirtek's annual report for 2025 and the release of 2026 guidance, we have updated our investment-case.

Wirtek